DanCann Pharma A/S enter exclusive agreement with Cannassure Therapeutics to be multinational distributor for Scandinavia (Denmark, Norway, Sweden, and Finland)
COPENHAGEN, Denmark, 15 December 2020 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby today announce that the Company has entered into an agreement (the “Distribution Agreement”) with Cannassure Therapeutics Ltd. (TASE: CSURE) (“Cannassure”) to be the exclusive multinational distributor of the Israelian-based company’s product portfolio for whole Scandinavia (“the Territory”).The Distribution Agreement Under the terms of the Distribution Agreement, DanCann Pharma will be the exclusive Scandinavian distributor for the product portfolio from Cannassure,